This activity is intended for primary care physicians, psychiatrists, neurologists, geriatricians, nurses/nurse practitioners, pharmacists, physician assistants, and other members of the healthcare team who care for adults with dementia.
The goal of this activity is for the healthcare team to be better able to evaluate dementia as a risk factor for suicide.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.
Medscape designates this continuing education activity for 0.25 contact hour(s) ( 0.025 CEUs) (Universal Activity Number: JA0007105-0000-22-388-H01-P).
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 12/2/2023. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 12/2/2022
Valid for credit through: 12/2/2023, 11:59 PM EST
processing....
Mood disorders are one of the most important comorbid conditions among patients with dementia, but what are the prevalence rates of symptoms of depression, anxiety, and apathy among adults with dementia, and does prevalence change as patients advance through different stages of dementia? Leung and colleagues answered these questions in a systematic review and meta-analysis. Their results were published in the April 27, 2021 issue of International Journal of Geriatric Psychiatry.[1]
The review netted 20 studies, which included a total of nearly 6000 adults. The prevalence rates of both depression and anxiety in mild, moderate, and severe dementia were 38%, 41%, and 37%, respectively. Apathy was more common and reported by 54%, 59%, and 43% of patients with mild, moderate, and severe dementia, respectively.
Overall, there was not a significant difference in the prevalence of depression, anxiety, or apathy in comparing the stages of dementia. The authors did not perform other subgroup analyses to establish other risks for these disorders.
Both mood disorders and dementia can contribute to a higher risk for suicide. The current study by Alothman and colleagues evaluates dementia as a risk factor for suicide.
Three subgroups of patients are at increased risk for suicide after a diagnosis of dementia: a finding that paves the way for more targeted suicide risk assessment and intervention, new research suggests.
In a large population-based, case-control study, results showed an increased risk for suicide among persons with younger-onset dementia, defined as being diagnosed before age 65 years, persons diagnosed within the previous 3 months, and persons who also had mental illness.
"Doctors should be aware that these groups are at increased risk and consider early signposting/referral to appropriate mental health services," senior investigators Charles Marshall, MRCP, PhD, clinical senior lecturer and honorary consultant neurologist, Wolfson Institute of Population Health, Queen Mary University of London, United Kingdom, told Medscape Medical News.
"Perhaps more importantly, the design and remuneration of dementia diagnosis services need to take account of the importance of providing adequate resources for postdiagnostic support and risk assessment," Marshall said.
The findings were published online October 3 in JAMA Neurology.[2]
Fear and WorryThe researchers reviewed the electronic medical records from 2001 to 2019 for approximately 594,000 adults. Among the 4940 adults diagnosed with dementia, 95 (1.9%) died by suicide.
There was no overall significant association between a dementia diagnosis and suicide risk (adjusted odds ratio [aOR] 1.05 [95% CI: 0.85, 1.29]); however, compared with adults who had not been diagnosed with dementia, suicide risk was significantly increased among peers diagnosed with dementia before age 65 years (aOR 2.82 [95% CI: 1.84, 4.33]).
The risk was more than 2-fold higher within the first 3 months of diagnosis (aOR 2.47 [95% CI: 1.49, 4.09]) and in persons with comorbid psychiatric illness (aOR 1.52 [95% CI: 1.21, 1.93]).
Among adults younger than 65 years who were within 3 months of diagnosis, suicide risk was nearly 7 times higher than among their peers without dementia (aOR 6.69 [95% CI: 1.49, 30.12]).
Adults with dementia who died by suicide were significantly younger at their time of death than peers with dementia who died of other causes (median age, 79.5 years vs 87.9 years).
"Given the current efforts to improve rates of dementia diagnosis, these findings emphasize the importance of concurrent implementation of suicide risk assessment for the identified high-risk groups," the investigators wrote.
Marshall noted that the elevated suicide risk after a dementia diagnosis in these subgroups may be due to a combination of the stress of diagnosis and neurodegenerative effects of the disease.
"A dementia diagnosis can be devastating, and many patients have fears for their future quality of life and fears that they may be a burden to those around them. In addition, we know that depression, anxiety, and social isolation can be early symptoms of Alzheimer's disease; and all of these may increase suicide risk too," Marshall said.
Examining "Devastating" OutcomesCommenting on the findings for Medscape Medical News, Beth Kallmyer, MSW, vice president of care and support for the Alzheimer's Association, said this large study is one of few that have examined the "devastating" psychological effects of being diagnosed with dementia.
For example, a study published last year showed that adults older than 65 years who were diagnosed with Alzheimer disease were twice as likely to die from suicide than older adults who did not have dementia, as reported by Medscape Medical News.
Receiving a diagnosis of Alzheimer disease at an early age is "rare, unexpected, and overwhelming -- making it very difficult to accept. The worry or fear about being a burden to family members can lead to thoughts of suicide," said Kallmyer, who was not involved with the research.
"Individuals diagnosed with younger-onset Alzheimer's face additional challenges because they are often raising families and taking care of their own parents. Losing their ability to work is especially devastating since they are often in the prime earning years," she said.
Kallmyer noted that it is common for individuals living with dementia to have suicidal thoughts, but having suicidal thoughts and taking action on them is very different.
"The signs to look for in a person living with Alzheimer disease are the same as any other situation: talking about wanting to die, fear of being a burden, feeling hopeless and helpless, withdrawing from friends and family, changes in sleeping and eating habits," she said.
She added that one of the most important things a healthcare provider can tell someone facing a dementia diagnosis is that they are not alone and that support is available.
The Alzheimer's Association has support groups and disease education programs for individuals living with Alzheimer disease, Kallmyer noted.
The study received no specific funding. Marshall and Kallmyer have reported no relevant financial relationships.
Figure. Factors That Increase Suicide Risk in Patients With Dementia
Implications for the Healthcare Team The healthcare team should be aware of a possible higher risk for suicide among patients diagnosed with dementia before age 65 years and among patients recently diagnosed with dementia. |